---
title: "Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Baxter International, Inc. – BAX"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/265405776.md"
description: "Pomerantz LLP has filed a class action lawsuit against Baxter International, Inc. for alleged securities fraud and unlawful business practices. Investors who purchased Baxter securities during the Class Period can contact Pomerantz to join the lawsuit by December 15, 2025. The lawsuit follows Baxter's announcement on July 31, 2025, of a temporary pause in shipments of its Novum LVP medical device, which led to a 22.4% drop in its stock price. Pomerantz LLP specializes in corporate and securities class litigation."
datetime: "2025-11-11T23:00:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265405776.md)
  - [en](https://longbridge.com/en/news/265405776.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265405776.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/265405776.md) | [繁體中文](https://longbridge.com/zh-HK/news/265405776.md)


# Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Baxter International, Inc. – BAX

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Baxter and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until December 15, 2025, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Baxter securities during the Class Period. A copy of the Complaint can be obtained at **www.pomerantzlaw.com****.**

\[Click here for information about joining the class action\]

On July 31, 2025, Baxter announced that it had decided to "voluntarily and temporarily pause shipments and planned installations of the Novum LVP", a medical device used for the controlled delivery of intravenous fluids, and that the Company was "unable to currently commit to an exact timing for resuming shipment and installation for Novum IQ LVPs." Baxter stated that they had offered "customers the option of our Spectrum infusion pump as an alternative" and that the Company's low-end guidance assumes that the Company does not resume shipments for Novum LVPs before the end of the year.

On this news, Baxter's stock price fell $6.29 per share, or 22.4%, to close at $21.76 per share on July 31, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

**SOURCE:** Pomerantz LLP

View the original press release on ACCESS Newswire

### 相关股票

- [Baxter (BAX.US)](https://longbridge.com/zh-CN/quote/BAX.US.md)

## 相关资讯与研究

- [EU regulator warns of shortage in Baxter's cancer treatment until early 2027](https://longbridge.com/zh-CN/news/280328406.md)
- [Pomerantz LLP Reminds Shareholders with Losses on their Investment in Baxter International, Inc. – BAX](https://longbridge.com/zh-CN/news/269714046.md)
- [BLUENERGIES ANNOUNCES TRADING ON OTCQX BEST MARKET UNDER THE TRADING SYMBOL "BLUGF" | BLUGF Stock News](https://longbridge.com/zh-CN/news/281007604.md)
- [Rightmove Vows Robust Defence Against Collective Action Bid](https://longbridge.com/zh-CN/news/281347584.md)
- [18:57 ETRosen Law Firm Encourages Hitek Global Inc. Investors to Inquire About Securities Class Action Investigation - HKIT](https://longbridge.com/zh-CN/news/281262924.md)